Chemopreventive therapy against Human Cancer: Isorhamnetin inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 2/November/2014, 9.33 am

Natural product-based therapy for Cancer: Combination of Quercetin and Hyperoside (QH) increases the expression of the tumor suppressor TPM1 via down regulation of its target gene, 1/November/2014, 22.31
November 1, 2014
Natural product-based therapy for traumatic brain injury (TBI): Prostaglandin E2 (PGE2) alleviates apoptosis of neuronal cells after traumatic brain injury via up regulation of its target gene, 2/November/2014, 9.48 am
November 2, 2014
Show all

The 1989 Nobel prize winner in Physiology/Medicine Prof. Varmus Harold E, Somwar R and others from High Throughput Screening Core Facility, and Organic Synthesis Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; and the US National Cancer Institute, USA has published a research paper in the 27 September 2011 issue of Proc Natl Acad Sci U S A. (I.F: >10) stating that “Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines.”  

Based on this this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: Chemopreventive therapy against Human Cancer: Isorhamnetin inhibits tumor cell proliferation via down regulation of  Superoxide dismutase 1 (SOD1).  This result  suggests that  Isorhamnetinby decreasing the expression of its target gene, it may decrease the expression of SOD1. Thereby, it may increase the levels of Superoxide anions in cancer cells, which in turn may increase the expression of a number of tumor suppressor genes.  Thus, pharmacological formulations encompassing “Isorhamnetin  or its analogues may be used to treat human cancers.

Idea Proposed/Formulated byDr L Boominathan Ph.D.


To citeBoominathan, Chemopreventive therapy against Human Cancer: Isorhamnetin   inhibits tumor cell proliferation via down regulation of  Superoxide dismutase 1 (SOD1), 2/November/2014, 9.33 am,  Genome-2-Bio-Medicine Discovery center (GBMD),

Undisclosed information: How Isorhamnetin  inhibits the expression of Superoxide dismutase 1 (SOD1). 

Terms & Conditions apply

Courtesy: When you cite drop us a line at

* Research cooperation

Comments are closed.